July 2018

Promise and Pitfalls of Preventing Migraine With CGRP Inhibitors

July 10, 2018

Cover Story

The FDA's approval of erenumab marked a milestone in migraine treatment, and although the calcitonin gene-related peptide inhibitor class is full of promise, it has overcome many pitfalls along the way.